EMVision Medical Devices

EMVision Medical Devices is an Australian public company focused on the research, development, and commercialization of innovative neurodiagnostic medical imaging technology, particularly for stroke diagnosis and monitoring. Founded on over a decade of research at The University of Queensland, the company aims to advance portable electromagnetic brain scanning technology to enable faster diagnosis and treatment of neurological conditions. EMVision offers two main devices: the emu™ Brain Scanner and the First Responder Brain Scanner. The emu™ is a bedside device designed for hospitals, providing rapid, AI-powered imaging to identify stroke types without ionizing radiation. The First Responder Brain Scanner is a lightweight helmet version for use by paramedics, allowing for stroke diagnosis at the scene of an emergency. Both devices are designed to be operated by trained healthcare professionals, enhancing accessibility in various healthcare settings. The company is led by CEO Dr. Ron Weinberger and Chairman John Keep, and it generated approximately AUD 11.56 million in revenue in 2024. EMVision is committed to making neurodiagnostic imaging accessible to all patients, improving stroke care worldwide.

• Employees 43
• Founded 2017
• Annual Revenue $3302000
• Total Funding $23150000